Mirion Technologies, Inc. reports company developments in radiation detection, measurement, analysis and monitoring solutions for nuclear, medical, defense and research markets. Updates commonly cover financial results, orders, guidance, investor presentations and leadership appointments across the Nuclear & Safety and Medical groups.
Mirion's recurring business themes include nuclear power customers, critical radiation safety applications, R&D labs, nuclear facilities and healthcare uses such as Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry and Diagnostic Imaging. News also reflects the completed Paragon Energy Solutions acquisition, which added engineered nuclear-power offerings and is being integrated into the Nuclear & Safety group.
Mirion Technologies (NYSE: MIR) has commenced trading on the New York Stock Exchange following its successful business combination with GS Acquisition Holdings Corp II. The company's Class A common stock and warrants are now trading under the symbols 'MIR' and 'MIRW'. With a fiscal year 2021 revenue of $612 million, reflecting a growth of 27.9% year-over-year, Mirion aims to expand its product offerings in industrial technology and medical sectors. CEO Thomas Logan anticipates continued growth and welcomes Larry Kingsley as Chairman to lead strategic initiatives.